Welcome back to this new edition of Apac CIO Outlook !!!✖
March 20198 There has been a sea change in the field of `healthcare' happening at a very rapid pace in the last decade or so. It involves redefining the key stakeholders, changing spheres of influence, evolving regulatory, legal, ethical and competitive landscapes, as well as focusing on `value based outcomes'. As the pharma pipeline dries up, the differentiation between different compounds in the same or similar classes of therapies becomes narrow with a strong need for enhancing the overall value proposition by different methods assumes importance. The `Beyond Beyond the pill' solution as I would love to call it is no more a matter of choice but a strategy to survive and grow. Use of technology across the healthcare value chain has emerged as the most 'disruptive' of all changes, eventually benefitting the stakeholders, shareholders included, by creating a win-win situation.The Pharma and the life sciences industries have traditionally been offering solutions by bringing innovative compounds, many of which grew up to become `Blockbusters' merely based on the efficacy and safety data, and `one size fits all model' to start with. However the scenario has changed fast and thick with each stakeholder questioning and demanding a more individualized approach and better solutions which are nimble, efficient, and convenient and can improve the quality of life and the overall wellbeing. This has given rise to finding THE QUEST FOR INTELLIGENT MEDICINE: IS TECHNOLOGY THE ANSWER?BY DR. SHAILENDRA BAJPAI, HEAD OF DISEASE MANAGEMENT AND STAKEHOLDER ENGAGEMENT, DIABETES AND CV EMERGING MARKETS, SANOFIsolutions through the use of technologies which can support the initiation, optimization and adherence to medications, beyond the classical `drug' ,`devices' and `service' models. This has given rise to an important stakeholder the technology providers who are increasingly becoming a `key' stakeholder in the whole value chain. For the first time, there has been more `Venture investing' in Health-tech or Med-tech than in Biotech in 2018.That tells it all. In addition to the new wave of `integrated care solutions by using technology there's a fast IN MY V EW < Page 7 | Page 9 >